Core Viewpoint - Sacco System, an Italian biotechnology company, has established a subsidiary named Siyike in Shanghai to deepen its integration into the Chinese probiotic market [1]. Group 1: Company Overview - Sacco System is a globally recognized biotechnology enterprise with products including lactic acid starters, probiotics, postbiotics, and enzyme preparations, operating in over 110 countries and regions [1]. - The company initiated its Asia-Pacific strategy in 2018, entering markets in Singapore, Japan, and Australia, and the opening of the Shanghai subsidiary marks the preliminary completion of its integrated "R&D - Production - Market" layout in the region [1]. Group 2: Market Insights - The Chinese probiotic market has been rapidly developing, becoming one of the most dynamic markets globally. According to Frost & Sullivan, the clinical probiotic market in China is projected to grow from approximately 6.5 billion yuan in 2022 to about 7.5 billion yuan in 2024, with an expected market size of around 10 billion yuan by 2028, reflecting a compound annual growth rate (CAGR) of 7.5% [1]. - The growth is driven by the "Healthy China" strategy and increasing consumer health awareness, leading to a rising demand for functional foods such as probiotics [1]. Group 3: Strategic Collaborations - Siyike has begun collaborations with Chinese brands such as Mengniu, serving both brand owners and contract manufacturers [2]. - The company aims to promote deep integration of Sino-European technology through a "dual-engine innovation" model, establishing a joint R&D platform to develop probiotics and fermentation technologies that align with Chinese dietary culture and health needs [2]. - Additionally, Siyike plans to conduct research on microbiomes that combines Italian fermentation techniques with local Chinese practices to create products and solutions that are more suited to the local market [2].

Core Insights - The article discusses Shanghai's action plan for accelerating food technology innovation from 2026 to 2030, aiming to enhance the food industry's development through synthetic biology and digital manufacturing [1][2]. Group 1: Goals and Objectives - By 2027, the plan aims to achieve significant breakthroughs in synthetic biology food creation, including the development and approval of 3-5 new food raw materials, additives, and related products, as well as 1-2 special medical purpose formula foods [2]. - The initiative seeks to cultivate over 5 innovative enterprises with core food creation technologies and digital manufacturing capabilities, and establish a comprehensive standard system for food industry development [2]. Group 2: Long-term Vision - By 2030, the goal is to create a globally influential hub for food technology innovation, resulting in a safer, healthier, more convenient, and sustainable food innovation ecosystem [3]. - The plan includes forming an innovation enterprise cluster covering the entire food industry chain, nurturing 8-10 leading companies in specific segments, and promoting 1-2 synthetic biology food innovation companies to go public [3]. - The food industry output value is projected to exceed 150 billion yuan, alongside the establishment of a national-level nutrition and health industry cluster and new food pilot parks [3]. Group 3: Research and Development Focus - The plan emphasizes accelerating the exploration of new food raw materials, focusing on functional proteins, carbohydrates, and lipids, while also considering active substances, flavors, and colorants [5]. - It aims to enhance biosynthesis technology through the integration of synthetic biology and artificial intelligence, improving the performance and adaptability of standardized components and chassis cells [5]. - Support for the development of new food products includes alternative proteins, plant-based meats, 3D-printed foods, and other innovative food solutions to meet diverse consumer needs and sustainable development goals [5].

Core Viewpoint - The Shanghai Municipal Science and Technology Commission, along with multiple departments, has issued the "Action Plan for Accelerating Food Technology Innovation to Empower Industrial Development (2026-2030)", which emphasizes support for the research and development of new food products [1] Group 1: New Food Development - The plan focuses on the development of alternative proteins, artificial meat, artificial milk, 3D-printed foods, and algae-based products [1] - It aims to create products with physiological regulatory functions, including active peptides, engineered probiotics, prebiotics, postbiotics, and food-medicine homologous products [1] - The initiative seeks to meet diverse food consumption needs, personalized nutrition and health demands, and sustainable development requirements [1]

Core Viewpoint - Keta Bio (300858) has obtained a food production license for its wholly-owned subsidiary in Inner Mongolia, expanding its business into probiotics and related products [1] Group 1: Business Expansion - The company will gradually release production capacity based on customer orders [1] - The product range includes probiotic raw materials, yogurt fermentation agents, postbiotics, and end-consumer probiotic products [1] Group 2: Market Strategy - The company is focusing on online market opportunities and has initiated compliant promotion and brand building on mainstream platforms [1] - Keta Bio is exploring live e-commerce and collaborations with influencers to enhance brand reputation and create popular products [1] - The goal is to continuously improve market influence [1]

Core Viewpoint - The company has obtained a food production license, indicating a significant step in its strategic planning and product development in the probiotics market [1] Group 1: Company Developments - The company's wholly-owned subsidiary, Inner Mongolia Ketaobiotechnology Co., Ltd., has acquired the food production license, which allows it to produce probiotic raw materials, yogurt fermentation agents, postbiotics, and probiotic consumer products [1] - The company plans to gradually release production capacity based on customer orders, ensuring an orderly production process [1] Group 2: Market Strategy - The company is focusing on online market opportunities and has initiated compliant promotion and brand building on mainstream platforms [1] - The company is exploring collaborations with live-streaming e-commerce and influencers to create popular products and enhance market influence [1]